Summary
The effect of prolonged treatment with acarbose, an inhibitor of α-glycosidase, has been studied in mice made obese and hyperinsulinaemic by goldthioglucose. After the onset of obesity, one month after goldthioglucose administration, mice were then treated, with or without a 10% sucrose supplement, for four months with acarbose, added to the diet at 50 mg/100 g food. When mice received a standard diet, acarbose had no effect on body weight, blood glucose or insulin levels. In contrast, in the control obese mice receiving a 10% sucrose-enriched diet, it decreased the body weight gain, and prevented the rise in glycaemia and insulinaemia. Basal (non insulin-stimulated) glucose uptake, which is decreased in isolated soleus muscle from untreated obese mice, returned to normal values under acarbose treatment. However, muscle insulin resistance was not improved in acarbose-treated obese mice at maximal and submaximal effective concentrations, despite a higher insulin binding in muscles of acarbose-treated obese than in control obese animals. Furthermore, insulin receptor autophosphorylation and tyrosine kinase activity were altered similarly in treated and untreated obese mice compared to lean mice.
Article PDF
Similar content being viewed by others
References
Assimacopoulos-Jeannet F, Jeanrenaud B (1976) The hormonal and metabolic basis of experimental obesity. Clin Endocrinol Metab 5: 337–365
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595–1607
Le Marchand-Brustel Y, Jeanrenaud B, Freychet P (1978) Insulin binding and effects in isolated soleus muscle of lean and obese mice. Am J Physiol 234: E348-E358
Jeanrenaud B (1979) Insulin and obesity. Diabetologia 17: 133–138
Cuendet GS, Loten EG, Jeanrenaud B, Renold AE (1976) Decreased basal, non insulin-stimulated glucose uptake and metabolism by skeletal soleus muscle isolated from obese-hyperglycemic (ob/ob) mice. J Clin Invest 58: 1078–1088
Crettaz M, Prentki M, Zaninetti D, Jeanrenaud B (1980) Insulin resistance in soleus muscle from obese Zucker rats. Involvement of several defective sites. Biochem J 186: 525–534
Kahn BB, Cushman SW (1985) Subcellular translocation of glucose transporters: role in insulin action and its perturbation in altered metabolic states. Diabetes Metab Rev 1: 203–227
Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, Meelheim D, Dohm GL (1987) Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 79: 1330–1337
Le Marchand-Brustel Y, Grémeaux T, Ballotti R, Van Obberghen E (1985) Insulin receptor tyrosine kinase is defective in skeletal muscle of insulin-resistant obese mice. Nature 315: 676–679
Le Marchand-Brustel Y, Freychet P (1982) Alteration of glycogen synthase activation by insulin in soleus muscles of obese mice. FEBS Lett 120: 205–208
Puls W, Keup U, Krause HP, Müller L, Schmidt DD, Thomas G, Truscheit E (1980) Pharmacology of a glucosidase inhibitor. Front Hormone Res 7: 235–247
Creutzfeldt W (ed) (1982) Proceedings First International Symposium on acarbose. Effects on carbohydrate and fat metabolism. Excerpta Medica, International Congress Series 594, Amsterdam
William-Olsson T (1986) α-Glucosidase inhibition in obesity. Acta Med Scand [Suppl] 706: 1–39
Lee SM (1982) The effect of chronic α-glycosidase inhibition on diabetic nephropathy in the db/db mouse. Diabetes 31: 249–254
Vasselli JR, Haraczkiewicz E, Maggio CA, Greenwood MRC (1983) Effects of a glucosidase inhibitor (Acarbose, BAY g 5421) on the development of obesity and food motivated behavior in Zucker (fafa) rats. Pharmacol Biochem Behavior 19: 85–95
Le Marchand Y, Freychet P, Jeanrenaud B (1978) Longitudinal study on the establishment of insulin resistance in hypothalamic obese mice. Endocrinology 102: 74–85
Grémeaux T, Tanti JF, Van Obberghen E, Le Marchand-Brustel Y (1987) Alteration of insulin receptor kinase in obese, insulinresistant mice. Biochimie 69: 387–393
Rochet N, Tanti JF, Grémeaux T, Van Obberghen E, Le Marchand-Brustel Y (1988) Effect of a thermogenic agent, BRL 26830A, on insulin receptors in obese mice. Am J Physiol 255: E101-E109
Desbuquois B, Aurbach GD (1971) Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 33: 732–738
Le Marchand-Brustel Y, Ballotti R, Van Obberghen E (1988) Insulin receptor kinase activity in states with altered insulin action. In: Kahn CR, Harrison LC (eds) Insulin receptors Part A: methods for the study of structure and function. Liss, New York, pp 163–179
Fehlmann M, Le Marchand-Brustel Y, Van Obberghen E, Brandenburg D, Freychet P (1982) Photoaffinity labelling of the insulin receptor in intact rat hepatocytes, mouse soleus muscle, and cultured human lymphocytes. Diabetologia 23: 440–444
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685
Braun S, Raymond WE, Racker E (1984) Synthetic tyrosine polymers as substrates and inhibitors of tyrosine-specific protein kinases. J Biol Chem 259: 2051–2054
Snedecor GW, Cochran WG (1967) Statistical methods, 6th edn. Iowa State University Press, Ames
Gammeltoft S, Van Obberghen E (1986) Protein kinase activity of the insulin receptor. Biochem J 235: 1–11
Rosen OM (1987) After insulin binds. Science 237: 1452–1458
Kahn CR, White MF (1988) The insulin receptor and the molecular mechanism of insulin action. J Clin Invest 82: 1151–1156
Lee SM, Bustamante SA, Koldovsky O (1983) The effect of alpha-glucosidase inhibition of intestinal disaccharidase activity in normal and diabetic mice. Metabolism 32: 793–799
Garvey WT, Huecksteadt TP, Matthei S, Olefsky JM (1988) Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus. J Clin Invest 81: 1528–1536
Zaninetti D, Greco-Perotto R, Assimacopoulos-Jeannet F, Jeanrenaud B (1989) Dysregulation of glucose transport and transporters in perfused hearts of genetically obese (fa/fa) rats. Diabetologia 32: 56–60
Kahn BB, Cushman SW, Flier JS (1989) Regulation of glucose transporter-specific mRNA levels in rat adipose cells with fasting and refeeding. Implications for in vivo control of glucose transporter number. J Clin Invest 83: 199–204
Freidenbérg GR, Henry RR, Klein HH, Reichart DR, Olefsky JM (1987) Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J Clin Invest 79: 240–250
Arner P, Pollare T, Lithell H, Livingston JN (1987) Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 437–440
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Le Marchand-Brustel, Y., Rochet, N., Grémeaux, T. et al. Effect of an α-glycosidase inhibitor on experimentally-induced obesity in mice. Diabetologia 33, 24–30 (1990). https://doi.org/10.1007/BF00586457
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00586457